Discontinuation report CLONAZEPAM
| Report ID | 28157 |
| Drug Identification Number | 02442043 |
| Brand name | CLONAZEPAM |
| Common or Proper name | CLONAZEPAM |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CLONAZEPAM |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | N03AE |
| ATC description | ANTIEPILEPTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-11-01 |
| Remaining supply date | 2018-04-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-12-12 | French | Compare |
| v3 | 2017-12-12 | English | Compare |
| v2 | 2017-11-06 | French | Compare |
| v1 | 2017-11-06 | English | Compare |
Showing 1 to 4 of 4